GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Market Cap

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Market Cap : ¥4,836.2 Mil (As of Mar. 27, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Jiangsu Jibeier Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥24.68. Jiangsu Jibeier Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 199.4 Mil. Therefore, Jiangsu Jibeier Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥4,922.0 Mil.

Jiangsu Jibeier Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥4,799.3 Mil) to Jun. 2024 (¥4,421.9 Mil) but then increased from Jun. 2024 (¥4,421.9 Mil) to Sep. 2024 (¥4,922.0 Mil).

Jiangsu Jibeier Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥4,266.0 Mil) to Dec. 2022 (¥4,004.3 Mil) but then increased from Dec. 2022 (¥4,004.3 Mil) to Dec. 2023 (¥5,935.3 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jiangsu Jibeier Pharmaceutical Co's Enterprise Value for Today is ¥3,769.9 Mil.


Jiangsu Jibeier Pharmaceutical Co Market Cap Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Market Cap Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - 4,875.45 4,266.02 4,004.30 5,935.35

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,721.68 5,935.35 4,799.29 4,421.95 4,921.96

Competitive Comparison of Jiangsu Jibeier Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Jibeier Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's Market Cap falls into.


;
;

Jiangsu Jibeier Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Jiangsu Jibeier Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥31.39*189.084
=¥5,935.3

Jiangsu Jibeier Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥24.68*199.431
=¥4,922.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Jiangsu Jibeier Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Jiangsu Jibeier Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Jibeier Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
Executives
Wu Ying senior management
Zhang Chun Director
Zhao Suo Fu senior management
Li Hai Dao Core technical personnel
Di Jian Zhong senior management
Qin Xu Feng Core technical personnel
Wu Xiu Gen Core technical personnel
Yu Xin Jun Directors, senior managers
Li Zhao Guang Core technical personnel
Geng Zhong Yi Directors, senior managers, core technical personnel
Hu Tao Director

Jiangsu Jibeier Pharmaceutical Co Headlines

No Headlines